Texas 2009 - 81st Regular

Texas House Bill HB4589

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to a state purchasing preference for certain pharmaceutical manufacturers.

Impact

The impact of HB4589 could lead to changes in how state agencies purchase pharmaceutical products, potentially favoring companies that align their business practices with state health programs. By establishing a preference for manufacturers participating in these programs, the bill strives to enhance the quality of health services provided to children and individuals suffering from kidney conditions. Observers of the bill may question how this preference will influence the competitive landscape among pharmaceutical manufacturers, particularly those who do not engage in these specific programs.

Summary

House Bill 4589 introduces a state purchasing preference for certain pharmaceutical manufacturers that participate voluntarily in specific state health care programs. This legislative measure is aimed at enhancing state procurement practices concerning pharmaceuticals by giving preference to manufacturers that are involved with the Texas Department of State Health Services' programs relevant to children with special health care needs and kidney health. The intention behind this bill is to support manufacturers who contribute to particular health initiatives, thereby promoting the accessibility of necessary pharmaceutical products for vulnerable populations in Texas.

Contention

Although specific points of contention surrounding HB4589 are not detailed in the available documents, such policies typically generate discussions about fairness in procurement processes and potential unintended consequences. Critics might argue that while the bill aims to benefit certain populations, it could inadvertently limit choices for state agencies, possibly restricting them from purchasing from potentially more cost-effective or innovative manufacturers that do not participate in the designated health programs. Ensuring a transparent and competitive bidding process while prioritizing public health needs will be crucial for the bill's implementation.

Companion Bills

No companion bills found.

Previously Filed As

TX HB4800

Relating to prohibited discriminatory practices by pharmaceutical drug manufacturers against patient assistance program applicants.

TX HB4990

Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.

TX SB2402

Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.

TX SJR14

Proposing a constitutional amendment requiring the periodic review of state and local tax preferences and providing an expiration date for certain tax preferences.

TX SB103

Relating to a periodic review and expiration dates of state and local tax preferences.

TX HB953

Relating to a periodic review and expiration dates of state and local tax preferences.

TX HJR60

Proposing a constitutional amendment requiring the periodic review of state and local tax preferences and the expiration of certain tax preferences if not reauthorized by law.

TX HB446

Relating to the terminology used in statute to refer to intellectual disability and certain references to abolished health and human services agencies.

TX SB332

Relating to the terminology used in statute to refer to intellectual disability and certain references to abolished health and human services agencies.

TX HB1773

Relating to a state employment preference for certain individuals who reside with veterans with a disability.

Similar Bills

No similar bills found.